Media outlets home in on news of potential virus vaccine for the elderly

News that researchers from the BDI and National University of Singapore (NUS) have adapted new cancer and pan-influenza vaccine technology to develop a COVID-19 vaccine targeted at the elderly was greeted with huge interest. Associate Professors Mireille Lahoud and Irina Caminschi, together with NUS collaborators, have spent 12 years developing a patented platform technology that triggers immunity against diseases ranging from cancer, influenza and other infectious diseases. They are using the technology to target the spike protein in SARS-CoV-2, part of the outer layer of the virus and critical for entry into cells.

Some of the wide range of television, radio, press and online outlets running the story included Channel 10 News, Channel 9 News, ABC Radio around Australia, dozens of regional papers, The Herald Sun and nationwide syndications, The National Tribune, The Canberra Times, The Straits Times (Singaporean) and SeniorsNews.